PMCB
PharmaCyte Biotech·NASDAQ
--
--(--)
--
--(--)
1.42 / 10
Underperform
Technically, PMCB is underperforming with a 1.42/10 score. Key bearish signals include a MACD Death Cross (score 1.87, avg return -2.98%), Long Upper Shadow (score 1.4, avg return 0.07%), and Long Lower Shadow (score 1.0, avg return -2.33%). These patterns dominate the recent candlestick landscape, suggesting downward momentum and a cautious outlook for near-term traders.
Analysis Checks(0/3)
Long Upper Shadow
Score1.4/10
Win Rate39.08%
Hist. Signals87
Avg Return0.07%
Score1.4/10
Win Rate39.08%
Hist. Signals87
Avg Return0.07%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.98%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.98%
Long Lower Shadow
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-2.33%
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-2.33%
Long Upper Shadow
Score1.4/10
Win Rate39.08%
Hist. Signals87
Avg Return0.07%
Score1.4/10
Win Rate39.08%
Hist. Signals87
Avg Return0.07%
Long Lower Shadow
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-2.33%
Score1/10
Win Rate38.03%
Hist. Signals71
Avg Return-2.33%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.98%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.98%
Technical Analysis of PMCB?
- PMCB presents a Underperform setup with a Technical Score of 1.42/10. Key technical indicators highlight an RSI of 39.66 and a MACD of -0.04, with the trend anchored by the 50-Day SMA at 0.87. Traders should monitor key support at 0.67 and resistance at 0.73.
